Emerging COX-2 inhibitors-based nanotherapeutics for cancer diagnosis and treatment
Ruiping Huang,
No information about this author
Yu Jiang,
No information about this author
Baoyue Zhang
No information about this author
et al.
Biomaterials,
Journal Year:
2024,
Volume and Issue:
315, P. 122954 - 122954
Published: Nov. 7, 2024
Language: Английский
Self-Healing Photothermal Nanotherapeutics for Enhanced Tumor Therapy through Triple Ferroptosis Amplification and Cascade Inflammation Inhibition
Yilin Zheng,
No information about this author
Fangying Zheng,
No information about this author
Ruofei Xu
No information about this author
et al.
ACS Applied Materials & Interfaces,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Sept. 17, 2024
The
therapeutic
effectiveness
of
photothermal
therapy
(PTT)
is
limited
by
heat
tolerance
and
PTT-induced
inflammation,
which
increases
the
risk
tumor
metastasis
recurrence.
Ferroptosis
combined
with
PTT
can
achieve
significant
effects.
In
this
work,
we
designed
self-healing
nanotherapeutics
to
effective
triple-amplified
ferroptosis
cascade
inflammation
inhibition
after
treatment.
After
ferroptosis-inducing
ability
mangiferin
(MF)
was
first
elucidated,
nanocomplex
PFeM,
coordinated
Fe
Language: Английский
Application of metal polyphenol nanonetworks in phototherapy
Siwei Li,
No information about this author
Meng Cui,
No information about this author
Chunxiu Cai
No information about this author
et al.
Coordination Chemistry Reviews,
Journal Year:
2025,
Volume and Issue:
539, P. 216743 - 216743
Published: April 23, 2025
Language: Английский
Ferroptosis by nanomaterials: targeting cancer stem cells and overcoming drug resistance
Xiaoman Wang,
No information about this author
Jing Luo,
No information about this author
Xuemei Zeng
No information about this author
et al.
Acta Materia Medica,
Journal Year:
2025,
Volume and Issue:
4(3)
Published: Jan. 1, 2025
Tumor
ferroptosis,
a
regulated
form
of
cell
death
driven
by
iron-dependent
lipid
peroxidation,
has
emerged
as
promising
therapeutic
strategy
for
combating
cancers,
particularly
in
cases
involving
cancer
stem
cells
(CSCs)
and
drug
resistance.
In
recent
years
nanomaterial-based
approaches
have
gained
significant
attention
the
potential
to
selectively
induce
ferroptosis
while
sparing
normal
tissues.
This
review
aims
provide
comprehensive
overview
current
state-of-the-art
utilizing
nanomaterials
targeting
tumor
with
specific
focus
on
application
eradicating
CSCs
overcoming
resistance
mechanisms.
The
molecular
mechanisms
underlying
induction
nanomaterials,
unique
properties
functionalities
various
nanomaterial
platforms,
strategies
using
nanoferroptosis
will
be
discussed.
addition,
preclinical
clinical
evidence
supporting
efficacy
platforms
evaluated.
Furthermore,
challenges
future
perspectives
development
translation
nanoferroptosis-based
therapies
precision
treatment
highlighted.
Language: Английский
Four birds with one Stone: A Lactose-Targeted supramolecular nanoprodrug for combined Photodynamic/Photothermal/NO/ chemotherapy of multidrug resistant cancer
Chang Du,
No information about this author
Jianbo Zhang,
No information about this author
Yingnan Zhou
No information about this author
et al.
Chemical Engineering Journal,
Journal Year:
2025,
Volume and Issue:
unknown, P. 163787 - 163787
Published: May 1, 2025
Language: Английский
Integration of Fe(III)-Chelated Polydopamine and Diallyl Trisulfide for Boosting Ferroptosis to Reverse Multidrug Resistance and Inducing Synergistic Tumor Nanotherapy
Yiwang Zhao,
No information about this author
Shunyu Yao,
No information about this author
Jing Huang
No information about this author
et al.
ACS Applied Nano Materials,
Journal Year:
2024,
Volume and Issue:
7(22), P. 25580 - 25592
Published: Nov. 2, 2024
Multidrug
resistance
(MDR)
has
long
been
a
fundamental
obstacle
in
tumor
chemotherapy.
MDR
is
often
associated
with
overexpression
of
an
adenosine
triphosphate
(ATP)-binding
cassette
transporter
resistant
cancer
cells,
which
highly
ATP-dependent.
Therefore,
reversing
by
down-regulated
ATP
expression
promising
strategy.
This
study
developed
redox-regulating
nanotherapeutic
for
boosting
ferroptosis,
MDR,
and
inducing
synergistic
therapy.
Fe(III)-chelated
polydopamine
(Fe-PDA)
the
key
to
design
such
nanotherapeutic,
laser
irradiation
can
speed
up
electron
transfer
between
Fe3+
Fe2+
production
hydroxyl
radical
(•OH).
Coating
layer
Fe-PDA
on
surface
mesoporous
silica
(MSN)-encapsulated
diallyl
trisulfide
(DATS),
doxorubicin
(DOX)
was
loaded
Fe-PDA.
Upon
triggering,
(DATS@MSN@Fe-PDA/DOX,
DMFPD)
produced
photothermal
(•OH)
hydrogen
sulfide
(H2S)
apoptotic
cell
death.
The
DATS
depleted
intracellular
glutathione
(GSH),
together
H2S
boosted
ferroptosis.
Ferroptosis
effectively
caused
mitochondrial
dysfunction,
thereby
suppressing
expression.
interactive
death
chemotherapy
sensitization
were
further
demonstrated
4T1
tumor-bearing
mouse
model
high
level
biosafety.
provides
strategy
clinical
theragnostics.
Language: Английский